Zoekresultaten - Portaal voor medische datamodellen (MDM-portaal)

Zoekresultaten filteren
Datamodellen selecteren

Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

3 Zoekresultaten.

Pulmonary Function Week 38 Mepolizumab HES NCT00086658 - Pulmonary Function Week 38

- 15-07-17 - 1 Formulier, 1 Itemgroep, 6 Data-elementen, 1 Taal

Itemgroep: Pulmonary Function Tests

Study part: Pulmonary Function Week 38/ Early Withdrawal visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Pulmonary Function Tests Week 16 Mepolizumab HES NCT00086658 - Pulmonary Function Tests Week 16

- 12-07-17 - 1 Formulier, 1 Itemgroep, 6 Data-elementen, 1 Taal

Itemgroep: Pulmonary Function Tests

Study part: Pulmonary Function Tests Week 16.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Pulmonary Function Tests Day 1 Pre-Infusion Mepolizumab HES NCT00086658 - Pulmonary Function Tests Day 1 Pre-Infusion

- 11-06-17 - 1 Formulier, 1 Itemgroep, 6 Data-elementen, 1 Taal

Itemgroep: Pulmonary Function Tests

Study part: Pulmonary Function Tests Day 1 Pre-Infusion.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.